Table 1.

Patient clinical profiles

PatientAgeSexMIWall motCurrent medications
β-blkCa-blkACE
163MNoModNoDiltiazemRamipril
260MYesModAtenololNoRamipril
355MYesMildAtenololDiltiazemRamipril
460MYesModAtenololNoNo
545MYesModAtenololNoRamipril
677MYesMildAtenololDiltiazemLisinopril
758MUncertainMildAtenololNoNo
842MYesModBisoprololNoPerindopril
971MDilatedSevereBisoprololNoNo
1058MYesSevereAtenololAmlodipinePerindopril
  • One patient had one-vessel heart disease, with all remaining patients having two-to-three vessel heart disease. In addition, patients 2 and 8 had undergone coronary artery surgical procedures; patients 7 and 10 had undergone angioplasty procedures; and patients 2, 9, and 10 had previous heart failure. MI, myocardial infarction; Wall mot, ventricular wall motion impairment; β-blk, beta blocker; Ca-blk, calcium channel blocker; ACE, angiotensin-converting enzyme inhibitor. M, male.